158 related articles for article (PubMed ID: 24679064)
21. Canadian marketing codes: how well are they controlling pharmaceutical promotion?
Lexchin J
Int J Health Serv; 1994; 24(1):91-104. PubMed ID: 8150569
[TBL] [Abstract][Full Text] [Related]
22. Pharmaceutical marketing strategies' influence on physicians' prescribing pattern in Lebanon: ethics, gifts, and samples.
Khazzaka M
BMC Health Serv Res; 2019 Jan; 19(1):80. PubMed ID: 30700295
[TBL] [Abstract][Full Text] [Related]
23. [Transparency in relations between multinational R&D pharmaceutical companies' corporate social responsibility activities and patient organizations in the Europe, Japan, and the United States].
Kato M; Ishikawa H; Okuhara T; Kiuchi T
Nihon Koshu Eisei Zasshi; 2019; 66(12):746-755. PubMed ID: 31875625
[TBL] [Abstract][Full Text] [Related]
24. Institutional barriers and enablers to implementing and complying with internationally accepted quality standards in the local pharmaceutical industry of Pakistan: a qualitative study.
Tauqeer F; Myhr K; Gopinathan U
Health Policy Plan; 2019 Jul; 34(6):440-449. PubMed ID: 31302684
[TBL] [Abstract][Full Text] [Related]
25. The House of Commons Health Committee: 'The Influence of the Pharmaceutical Industry'. Too much too late?
Kerwin R
J Psychopharmacol; 2007 Mar; 21(2):131-3. PubMed ID: 17329287
[No Abstract] [Full Text] [Related]
26. [Drug advertising and promotion: regulations and extent of compliance in five Latin American countries].
Vacca C; Vargas C; Cañás M; Reveiz L
Rev Panam Salud Publica; 2011 Feb; 29(2):76-83. PubMed ID: 21437364
[TBL] [Abstract][Full Text] [Related]
27. Unhealthy marketing of pharmaceutical products: An international public health concern.
Mulinari S
J Public Health Policy; 2016 May; 37(2):149-59. PubMed ID: 26911654
[TBL] [Abstract][Full Text] [Related]
28. Pharmaceutical gift giving: analysis of an ethical dilemma.
Stokamer CL
J Nurs Adm; 2003 Jan; 33(1):48-51. PubMed ID: 12544625
[TBL] [Abstract][Full Text] [Related]
29. Prescription data mining and the protection of patients' interests.
Orentlicher D
J Law Med Ethics; 2010; 38(1):74-84. PubMed ID: 20446986
[TBL] [Abstract][Full Text] [Related]
30. "But doctors do it...": nurses' views of gifts and information from the pharmaceutical industry.
Jutel A; Menkes DB
Ann Pharmacother; 2009 Jun; 43(6):1057-63. PubMed ID: 19470854
[TBL] [Abstract][Full Text] [Related]
31. Adherence of Drug Promotional Literatures Distributed by Pharmaceutical Companies to World Health Organization Ethical Criteria for Medicinal Drug Promotion.
Prasad P; Bajracharya SR; Deo S; Lamichhane S; Pradhan PMS; Ghimire R; Pokharel A
J Nepal Health Res Counc; 2019 Nov; 17(3):345-350. PubMed ID: 31735930
[TBL] [Abstract][Full Text] [Related]
32. Activities of the International Federation of Pharmaceutical Manufacturers Associations in world health.
Cone M
J Clin Epidemiol; 1991; 44 Suppl 2():45S-47S. PubMed ID: 2045841
[TBL] [Abstract][Full Text] [Related]
33. Evolving Communication with Healthcare Professionals in the Pharmaceutical Space: Current Trends and Future Perspectives.
Krendyukov A; Nasy D
Pharmaceut Med; 2020 Aug; 34(4):247-256. PubMed ID: 32557342
[TBL] [Abstract][Full Text] [Related]
34. Exposing nursing students to the marketing methods of pharmaceutical companies.
Civaner M; Sarikaya O; Alici SU; Bozkurt G
Nurs Ethics; 2008 May; 15(3):396-410. PubMed ID: 18388173
[TBL] [Abstract][Full Text] [Related]
35. Risk Communication and the Pharmaceutical Industry: what is the reality?
Edwards B; Chakraborty S
Drug Saf; 2012 Nov; 35(11):1027-40. PubMed ID: 23061779
[TBL] [Abstract][Full Text] [Related]
36. A comparison of codes of pharmaceutical marketing practices.
Guha A
Indian J Med Ethics; 2004; 1(1):19-21. PubMed ID: 16370064
[No Abstract] [Full Text] [Related]
37. Complaints about Violations of Voluntary and Pharmaceutical Industry-Run Medicine Promotion Codes in Canada.
Lexchin J
Int J Soc Determinants Health Health Serv; 2023 Oct; 53(4):518-527. PubMed ID: 36938584
[TBL] [Abstract][Full Text] [Related]
38. Misleading advertising for antidepressants in Sweden: a failure of pharmaceutical industry self-regulation.
Zetterqvist AV; Mulinari S
PLoS One; 2013; 8(5):e62609. PubMed ID: 23650519
[TBL] [Abstract][Full Text] [Related]
39. Global marketing of cholesterol-lowering drugs as therapy.
Elimimian JU; Gilmore JM; Singletary TJ
J Hosp Mark Public Relations; 2006; 16(1-2):15-28. PubMed ID: 17194684
[TBL] [Abstract][Full Text] [Related]
40. Ethical code of the pharmaceutical industry in Slovakia. (Excerpts).
Med Etika Bioet; 2004; 11(3-4):11-22. PubMed ID: 16294449
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
